Genomic Complexity Predicts Resistance to Endocrine Therapy and CDK4/6 Inhibition in Hormone Receptor–Positive (HR+)/HER2-Negative Metastatic Breast Cancer
暂无分享，去创建一个
F. Ademuyiwa | R. Suresh | S. Jia | L. Hernandez-Aya | B. King | Cynthia X. Ma | L. Peterson | K. Weilbaecher | K. Clifton | C. Rigden | P. Du | J. Krishnamurthy | T. Zheng | X. Dong | A. Frith | A. Davis | T. Rearden | Jingqin R Luo | P. Tandra | C. Dai | S. Thomas | T. Summa | Brittney Haas | Kemin Zhou | Lu Tan | Shujun J Luo | Xiaohong Wang